Pneumococcal vaccine: clinical factors as facilitators or barriers to vaccination

A. Vila Corcoles, O. Ochoa Gondar, I. Guinea, M. Juarez, F. Ester, EVAN STUDY GROUP (Tarragona, Spain)

Source: Annual Congress 2005 - Respiratory disease management in primary care
Session: Respiratory disease management in primary care
Session type: Thematic Poster Session
Number: 3524
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Vila Corcoles, O. Ochoa Gondar, I. Guinea, M. Juarez, F. Ester, EVAN STUDY GROUP (Tarragona, Spain). Pneumococcal vaccine: clinical factors as facilitators or barriers to vaccination. Eur Respir J 2005; 26: Suppl. 49, 3524

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pneumococcal vaccination practices and recommendations around the world
Source: International Congress 2017 – Global challenges in respiratory medicine
Year: 2017


Pneumococcal vaccination: current and future issues
Source: Eur Respir J 2001; 18: 184-195
Year: 2001



Addressing the challenge of vaccine hesitancy: an educational programme
Source: International Congress 2019 – Improving respiratory health through education
Year: 2019


Societal perspective and challenges of influenza and pneumococcal vaccination in patients at risk of respiratory complications
Source: Annual Congress 2008 - Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives
Year: 2008

Assessment of medical undergraduates’ relation to pneumococcal conjugate vaccine use
Source: Virtual Congress 2021 – Medical education in respiratory medicine
Year: 2021


Beliefs and attitudes of health care workers on influenza and pneumococcal vaccine
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012

Efficacy of vaccination to prevent pneumococcal infection in organized communities
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Pandemic influenza: using evidence on vaccines and antivirals for clinical decisions and policy making
Source: Eur Respir J 2006; 27: 661-663
Year: 2006


Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Source: Eur Respir J 2004; 23: 363-368
Year: 2004



Serotype dynamics in pneumococcal diseases and the performance of vaccination strategies for older adults in germany
Source: Virtual Congress 2020 – How do different treatment strategies translate into costs
Year: 2020




Pneumococcal vaccination
Source: Eur Respir J 2005; 26: 982-983
Year: 2005


Pneumococcal polysaccharide vaccination in COPD patients - some problems with antibody-response
Source: Eur Respir J 2002; 20: Suppl. 38, 472s
Year: 2002

Exploring determinants of acceptance of swine flu vaccination in nurses
Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease
Year: 2010

Influenza and pneumococcal immunization initiates work
Source: Eur Respir J 2001; 18: Suppl. 33, 207s
Year: 2001

Influenza and pneumococcal vaccination
Source: International Congress 2017 – State of the art session: "Respiratory infections"
Year: 2017


The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012